

30 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/30/3264623/20739/en/Ultragenyx-Announces-FDA-Clearance-of-Investigational-New-Drug-IND-Application-for-UX016-a-Sialic-Acid-Prodrug-for-the-Treatment-of-GNE-Myopathy.html

04 Nov 2024
// PRESS RELEASE